Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving nucleic acid
Patent
1997-06-23
1999-10-12
Saunders, David
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving nucleic acid
435 29, 435 30, C12Q 168
Patent
active
059653663
ABSTRACT:
Methods of identifying a patient having an altered immune status involve determining an immune status index for the patient and comparing it to the immune status index in healthy individuals. In general, an immune status index is the ratio of the amount of a protein that varies significantly in a patient with an altered immune status to the amount of another protein that is substantially invariant in both healthy and immune-altered individuals. Variable proteins can be TCR subunit proteins, T lymphocyte signal transduction pathway proteins, polynucleotide binding proteins or biological response modifiers (BRM). In addition, the ratio of a TH-1-type BRM to a TH-2-type BRM, the ratio of cytoplasmic to nuclear levels of polynucleotide binding proteins, the pattern of protein binding to an oligonucleotide probe that comprises the protein binding region of a gene for a BRM, or the pattern of distribution of T lymphocytes in a density gradient following density gradient centrifugation are also suitable as an immune status index. The methods are useful in identifying patients exhibiting immunosuppression, hyperimmunity and autoimmunity, as well as in assessing the immune status of a patient undergoing organ transplant.
REFERENCES:
patent: 5128270 (1992-07-01), Delacroix et al.
patent: 5246831 (1993-09-01), Skaletsky et al.
patent: 5260186 (1993-11-01), Cercek et al.
patent: 5296353 (1994-03-01), Ochoa et al.
patent: 5426029 (1995-06-01), Rittershaus et al.
patent: 5556763 (1996-09-01), Ochoa et al.
P. A. Baeuerle, "The Inducible Transcription Activator NF--.sub.k B: Regulation by Distinct Protein Subunits", Biochimica et Biophysica Acta., 1072, (1991), pp. 63-80.
Farrar et al., "5-Azacytidine Treatment of a Murine Cytotoxic T Cell Line Alters Interferon-.gamma. Gene Induction by Interleukin 2", J. of Immunology, vol. 135, No. 3, Sep. 1985, pp. 1551-1554.
Gray et al., "Structure of the Human Immune Interfone Gene", Dept. of Molecular Bio., vol. 298, No. 26, Aug. 1992, pp. 859-863.
Hardy et al., "Regulation of Expression of the Human Interfone.gamma. Gene", Proc. Natl. Acad. Sci., vol. 82, Dec. 1985, pp. 8173-8177.
Hu-Li et al., "Derivation of a T Cell Line That is Highly Responsive to IL-4 and IL-2 (CT.4R) and of an IL-2 Hyporesponsive Mutant of That Line", J. of Immunology, vol. 42, No. 3, Feb. 1989.
Kaye et al., "Both a Monoclonal Antibody and Antisera Specific for Determinants Unique to Individual Cloned Helper T Cell Lines Can Substitute for Antigen and Antigen-Presenting Cells in the Activation of T Cells*", J.Exp. Med., vol. 158, Sep. 1983, pp. 836-856.
Lederer et al., "Regulation of Cytokine Gene Expression in T Helper Cell Subsets", J. of Immunology, 1994, pp. 77-86.
Mizoguchi et al., "Alterations in Signal Transduction Molecules in T Lymphocytes from Tumor-Bearing Mice", Science, vol. 258, Dec. 1992, pp. 1795-1798.
Munoz et al., "Control of Lymphokine Expression in T Helper 2 Cells", Proc. Natl. Acad. Sci., vol. 86, Dec. 1989, pp. 9461-9464.
Norihisa et al., "Increased Proliferation, Cytotoxicity, and Gene Expression after Stimulation of Human Peripheral blood T Lymphocytes through a Surface Ganglioside (GD3).sup.1 ", J. of Immun., Oct., pp. 487-495.
Novak et al., cAMP Inhibits Induction of Interleukin 2 But Not of Interleukin 4 in T Cells, Proc. Natl. Acad. Sci., vol. 87, Dec. 1990, pp. 9353-9357.
Pang et al., "Interferon .gamma.2, Protein Kinase C Activators, and Possible Effect of Hypomethylation on Gene Regulation", vol. 80, No. 3, Aug. 1992, pp. 724-732.
Weiss et al., "Role T3 Surface Molecules in Human T-cell Activation: T3-dependent Activation Results in an Increase in cytoplasmic free calcium", Proc. Natl. Acad. Sci., Vol. 81, Jul. pp. 4169-4173.
Samelson et al., "Association of the Fyn Protein-Tyrosine Kinase with the T-Cell Antigen Receptor", Proc. Natl. Acad. Sci., vol. 87, Jun. 1990, pp. 4358-4362.
Samelson et al., "Antigen Activation of Murine T Cells Induces Tyrosine Phosphorylation of a Polypeptide Associated with the T Cell Antigen Receptor", vol. 46, 1986, pp. 1083-1090.
Patel et al., "Multiple Kinases and Signal Transduction", J. of Bio. Chem., vol. 262, No. 12, Apr. 1987, pp. 5831-5838.
Lewis et al., "Restricted Production of Interleukin 4 by Activated Human T Cells", Proc. Natl. Acad. Sci., vol. 85, pp. 9743-9747.
Richard D. Klausner, "Architectural Editing: Determinating the Fate of Newly Synthesized Membrane Proteins", The New Bio., vol. 1, Oct. 1989, pp. 3-8.
Klausner et al., "T Cell Antigen Receptor Activation Pathways: The Tyrosine Kinase Connection", vol. 64, Mar. 1991, pp. 875-878.
Koning et al., "The Implications of Subunit Interactions for the Structure of the T Cell Receptor-CD-3 Complex", Eur.J. Immun., vol. 20, 1990, pp. 299-305.
Klausner et al., "The T Cell Antigen Receptor: Insights into Organelle Biology.sup.1 ", Annu. Rev. Cell Bio., vol. 6, 1990, pp. 403-431.
June et al., "Increases in Tyrosine Phosporylation are Detectable before Phospholipase C Activation after T Cell Receptor Stimulation.sup.1 ", J. of Immun., vol. 144, No. 5, Mar. 1990, pp. 1591-1599.
Imoden et al., "Transmembrane Signaling by the T Cell Antigen Receptor", J. Exp. Med., vol. 161, Mar. 1985, pp. 446-456.
Hsi et al., "T Cell Activation Induces Rapid Tyrosine Phosphorylation of a Limited Number of Cellular Substrates*", J. of Bio. Chem., vol. 264, No. 18, Jun. 1989, pp. 10836-10842.
Blumberg et al., "Structure of the T Cell Antigen Receptor: Evidence for Two CD3.epsilon.", Proc. Natl. Acad. Sci., vol. 87, Sep. 1990, pp. 7220-7224.
Berridge et al., "Inosital Phosphates and Cell Signaling ", Nature, vol. 341, Sep. 1989, pp. 197-205.
P. Ghosh et al., "Alterations in NF.sub.k B/Rel Family Proteins in Splenic T-Cells from Tumor-bearing Mice and Reversal following Therapy", Cancer Research 54: 2969-2972 (1994).
P. Scott, "IL-12: Initiation Cytokine for Cell-Mediated Immunity", Science 260: 496-497 (1993).
Ghosh Paritosh
Longo Dan L.
Ochoa Augusto C.
Young Howard A.
Biormia USA Inc.
Saunders David
The United States of America as represented by the Secretary, De
LandOfFree
Methods of identifying patients having an altered immune status does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods of identifying patients having an altered immune status, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods of identifying patients having an altered immune status will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-650969